Haploidentical transplantation: repurposing cyclophosphamide.

[1]  M. Konopleva,et al.  Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  J. Wingard,et al.  Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. , 2011, Blood.

[3]  M. Petri,et al.  High-Dose Cyclophosphamide Without Stem Cell Rescue in 207 Patients With Aplastic Anemia and Other Autoimmune Diseases , 2011, Medicine.

[4]  H. Einsele,et al.  Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. , 2010, Blood.

[5]  Ashkan Emadi,et al.  Cyclophosphamide and cancer: golden anniversary , 2009, Nature Reviews Clinical Oncology.

[6]  Arnon Nagler,et al.  A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. , 2008, Blood.

[7]  Allen R. Chen,et al.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  Satkiran S. Grewal,et al.  Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? , 2003, Blood.

[9]  R. Iannone,et al.  Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide. , 2001, Blood.

[10]  J P Klein,et al.  Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Owens,et al.  THE INDUCTION OF GRAFT VERSUS HOST DISEASE IN MICE TREATED WITH CYCLOPHOSPHAMIDE , 1968, The Journal of experimental medicine.

[12]  Owens Ah,et al.  A COMPARISON OF THE EFFECTS OF SELECTED CYTOTOXIC AGENTS ON ALLOGENEIC SKIN GRAFT SURVIVAL IN RATS. , 1965 .